Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jitka Mlčochová"'
Autor:
Georgios Valianatos, Barbora Valcikova, Katerina Growkova, Amandine Verlande, Jitka Mlcochova, Lenka Radova, Monika Stetkova, Michaela Vyhnakova, Ondrej Slaby, Stjepan Uldrijan
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0185801 (2017)
MdmX overexpression contributes to the development of cancer by inhibiting tumor suppressor p53. A switch in the alternative splicing of MdmX transcript, leading to the inclusion of exon 6, has been identified as the primary mechanism responsible for
Externí odkaz:
https://doaj.org/article/388e2b6385c949e7a4f75a34a9d44a06
Autor:
Marian Hajduch, Jitka Mlčochová, Zbynek Bortlicek, Ondrej Slaby, Tomas Buchler, Petra Vychytilova-Faltejskova, Ales Ryska, Jiri Drabek, Igor Kiss, Marek Svoboda, Stanislav Batko, Alexandr Poprach
Publikováno v:
Anticancer Research. 36:4955-4960
Background: In metastatic colorectal cancer (mCRC), panitumumab is generally considered to be ineffective after the progression on cetuximab therapy. However, few studies have demonstrated that a small subset of mCRC patients may benefit from panitum
Autor:
Ondrej Slaby, Marek Svoboda, Nithyananda Thorenoor, Jitka Mlčochová, Petra Faltejskova-Vychytilova, Markus Kretz, Sonja Hombach
Publikováno v:
Oncotarget
We determined expression of 83 long non-coding RNAs (lncRNAs) and identified ZFAS1 to be significantly up-regulated in colorectal cancer (CRC) tissue. In cohort of 119 CRC patients we observed that 111 cases displayed at least two-times higher expres
Autor:
Manuela Ferracin, Jitka Mlčochová, Stanislav John, Barbara Zagatti, Igor Kiss, Petra Faltejskova-Vychytilova, Massimo Negrini, Ondrej Slaby, Marek Svoboda, Radim Nemecek, Rostislav Vyzula, Lenka Radová
Publikováno v:
Oncotarget
// Jitka Mlcochova 1 , Petra Faltejskova-Vychytilova 1, 2 , Manuela Ferracin 3 , Barbara Zagatti 3 , Lenka Radova 1 , Marek Svoboda 2 , Radim Nemecek 2 , Stanislav John 4 , Igor Kiss 2 , Rostislav Vyzula 2 , Massimo Negrini 3 , Ondrej Slaby 1, 2 1 Ce
Autor:
Monika Stetkova, Michaela Vyhnakova, Barbora Valčíková, Jitka Mlčochová, Amandine Verlande, Lenka Radová, Ondrej Slaby, Stjepan Uldrijan, Katerina Growkova, Georgios Valianatos
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 10, p e0185801 (2017)
PLoS ONE, Vol 12, Iss 10, p e0185801 (2017)
MdmX overexpression contributes to the development of cancer by inhibiting tumor suppressor p53. A switch in the alternative splicing of MdmX transcript, leading to the inclusion of exon 6, has been identified as the primary mechanism responsible for
Autor:
Marek Svoboda, Jitka Mlčochová, Igor Kiss, Alexandr Poprach, Jana Halámková, Rostislav Vyzula, Ondrej Slaby, Pavel Fabian, Kamila Součková
Publikováno v:
Oncology Letters
Bevacizumab is a humanized anti-vascular endothelial growth factor monoclonal antibody, used in combination with a oxaliplatin-based chemotherapy in the treatment of metastatic colorectal cancer (mCRC). The aim of the present study was to identify mi
Publikováno v:
Journal of Cancer Research and Clinical Oncology
MicroRNAs (miRNAs) are short, 18-25-nucleotide long, non-coding single-stranded RNAs, which are capable to regulate gene expression on post-transcriptional level through binding to their target protein-encoding mRNAs. miRNAs regulate individual compo
Autor:
Ondrej Slaby, Tomas Kazda, Lenka Radová, Radim Nemecek, Jitka Berkovcová, Marek Svoboda, Jitka Mlčochová, Petra Vychytilova-Faltejskova
Publikováno v:
OncoTargets and therapy
Radim Nemecek,1 Jitka Berkovcova,2 Lenka Radova,3 Tomas Kazda,4 Jitka Mlcochova,3 Petra Vychytilova-Faltejskova,1,3 Ondrej Slaby,1,3 Marek Svoboda1 1Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Masaryk University, Brno,
Autor:
Jitka Mlčochová, Petra Faltejsková, Andrej Bešše, Ondrej Slaby, Katerina Slaba, Jana Nekvindová, Igor Kiss, Marek Svoboda, Rostislav Vyzula, Klara Srutova, Pavel Fabian, Lenka Radová
Publikováno v:
Journal of Cellular and Molecular Medicine
MicroRNAs (miRNAs) constitute a robust regulatory network with post-transcriptional regulatory efficiency for almost one half of human coding genes, including oncogenes and tumour suppressors. We determined the expression profile of 667 miRNAs in col
Autor:
Jitka Mlčochová, Michal Staník, Zuzana Ozanova, Jiri Sana, Barbora Peltanová, Jan Dolezel, Jaroslav Juracek, Michal Fedorko, Tana Machackova, Hana Mlčochová, Ondrej Slaby, Robert Iliev
Publikováno v:
Cancer Research. 76:1946-1946
Urothelial carcinoma of the urinary bladder (UCUB) is the most common malignancy of the urinary system. Although about 80% of cases is a non-muscle invasive form of UCUB a high rate of local recurrence and progression to invasive form is observed. Ea